Frank Neumann
About Frank Neumann
Frank Neumann serves as the Senior Vice President and Global Head of Clinical Development at Kite Pharma. He has held various leadership roles in the pharmaceutical industry, including positions at AstraZeneca, MD Anderson Cancer Center, Takeda, and Verastem Oncology.
Current Role at Kite Pharma
Frank Neumann serves as the Senior Vice President and Global Head of Clinical Development at Kite Pharma. He has held this position since 2021, overseeing clinical development strategies and initiatives. His role involves managing clinical trials and ensuring compliance with regulatory standards in the development of innovative therapies.
Previous Experience at Takeda
Before joining Kite Pharma, Frank Neumann worked at Takeda for five years, from 2014 to 2019. He held multiple roles, including Senior Medical Director and Head of Clinical Development for Cell Therapy. His tenure at Takeda involved leading clinical development efforts and contributing to the advancement of oncology treatments.
Experience at AstraZeneca
Frank Neumann was employed at AstraZeneca as a Senior Director Physician for one year, from 2013 to 2014. His work took place in the Houston area of Texas, where he contributed to clinical strategies and physician oversight within the organization.
Research Scholar at MD Anderson Cancer Center
In 2010, Frank Neumann served as a Research Scholar at MD Anderson Cancer Center for nine months. This role involved conducting research in a leading cancer treatment and research institution, contributing to advancements in oncology.
Role at Verastem Oncology
Frank Neumann briefly worked as the Chief Medical Officer at Verastem Oncology in 2021 for one month. During this time, he was responsible for overseeing medical strategies and clinical development within the organization.